Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
LC Cappelli, AK Gutierrez, AN Baer… - Annals of the …, 2017 - ard.bmj.com
Objectives Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated
protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways have …
protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways have …
Hypocomplementemic urticarial vasculitis syndrome: clinical and serologic findings in 18 patients
JJ Wisnieski, AN Baer, J Christensen, TR Cupps… - Medicine, 1995 - journals.lww.com
Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical... : Medicine
Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical and Serologic Findings in 18 …
Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical and Serologic Findings in 18 …
Guillain‐Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy
ISJ Shin, AN Baer, HJ Kwon… - … : Official Journal of …, 2006 - Wiley Online Library
Objective Diverse neurologic syndromes have been described in association with tumor
necrosis factor α (TNFα) antagonist therapy for inflammatory arthritides and Crohn's disease. …
necrosis factor α (TNFα) antagonist therapy for inflammatory arthritides and Crohn's disease. …
Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry
…, SC Shiboski, CH Shiboski, AN Baer… - Arthritis care & …, 2012 - Wiley Online Library
Objective To study the prevalence of extraglandular manifestations in primary Sjögren's
syndrome (SS) among participants enrolled in the Sjögren's International Collaborative Clinical …
syndrome (SS) among participants enrolled in the Sjögren's International Collaborative Clinical …
Malignancy in myositis
ZA Zahr, AN Baer - Current rheumatology reports, 2011 - Springer
Dermatomyositis is associated with an underlying malignancy in about 24% of cases. This
association is also true for polymyositis but is less prominent. The malignancy is usually an …
association is also true for polymyositis but is less prominent. The malignancy is usually an …
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
…, C Cheadle, AG Tzioufas, AN Baer… - Proceedings of the …, 2012 - National Acad Sciences
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
Blunted erythropoietin response to anaemia in rheumatoid arthritis
AN Baer, EN Dessypris, E Goldwasser… - British journal of …, 1987 - Wiley Online Library
The relationship of serum immunoreactive erythropoietin to haemoglobin concentration was
defined for 54 patients with rheumatoid arthritis (RA) and 41 patients with anaemia of …
defined for 54 patients with rheumatoid arthritis (RA) and 41 patients with anaemia of …
Molecular subsetting of interferon pathways in Sjögren's syndrome
JC Hall, AN Baer, AA Shah, LA Criswell… - Arthritis & …, 2015 - Wiley Online Library
Objective Sjögren's syndrome (SS) is an autoimmune disease that targets the salivary and
lacrimal glands. While all patients demonstrate inflammatory infiltration and abnormal …
lacrimal glands. While all patients demonstrate inflammatory infiltration and abnormal …
Sicca syndrome associated with immune checkpoint inhibitor therapy
Background The objective of this study was to characterize the clinicopathologic features of
sicca syndrome associated with immune checkpoint inhibitor (ICI) therapy. Subjects, …
sicca syndrome associated with immune checkpoint inhibitor (ICI) therapy. Subjects, …
Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
G Stojan, AN Baer - Expert review of clinical immunology, 2012 - Taylor & Francis
Systemic lupus erythematosus is a systemic autoimmune disease that primarily affects
women in their reproductive age years. Pregnancy in systemic lupus erythematosus now has …
women in their reproductive age years. Pregnancy in systemic lupus erythematosus now has …